{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SASRS-COV-2", "flavonols", "influenza virus", "medicinal plants", "quercetin", "quercetin derivatives"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33374214", "DateCompleted": {"Year": "2021", "Month": "01", "Day": "12"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10", "10.3390/biom11010010"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Dec", "Day": "24"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus.", "Abstract": {"AbstractText": ["The medical burden caused by respiratory manifestations of influenza virus (IV) outbreak as an infectious respiratory disease is so great that governments in both developed and developing countries have allocated significant national budget toward the development of strategies for prevention, control, and treatment of this infection, which is seemingly common and treatable, but can be deadly. Frequent mutations in its genome structure often result in resistance to standard medications. Thus, new generations of treatments are critical to combat this ever-evolving infection. Plant materials and active compounds have been tested for many years, including, more recently, active compounds like flavonoids. Quercetin is a compound belonging to the flavonols class and has shown therapeutic effects against influenza virus. The focus of this review includes viral pathogenesis as well as the application of quercetin and its derivatives as a complementary therapy in controlling influenza and its related symptoms based on the targets. We also touch on the potential of this class of compounds for treatment of SARS-COV-2, the cause of new pandemic."]}, "AuthorList": [{"Identifier": ["0000-0002-8391-9228"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Influenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran 1316943551, Iran."}], "LastName": "Mehrbod", "ForeName": "Parvaneh", "Initials": "P"}, {"Identifier": ["0000-0002-9110-2314"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laryngology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-027 Katowice, Poland."}], "LastName": "Hudy", "ForeName": "Dorota", "Initials": "D"}, {"Identifier": ["0000-0002-4884-6983"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Center, Silesian University of Technology, 44-100 Gliwice, Poland."}], "LastName": "Shyntum", "ForeName": "Divine", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laryngology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-027 Katowice, Poland."}], "LastName": "Markowski", "ForeName": "Jaros\u0142aw", "Initials": "J"}, {"Identifier": ["0000-0001-9518-1411"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Pomeranian Medical University, 71-344 Szczecin, Poland."}], "LastName": "\u0141os", "ForeName": "Marek J", "Initials": "MJ"}, {"Identifier": ["0000-0001-5948-508X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada."}], "LastName": "Ghavami", "ForeName": "Saeid", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}], "MeshHeadingList": [{"QualifierName": ["epidemiology", "metabolism"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Disease Outbreaks"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Influenza A virus"}, {"QualifierName": ["drug therapy", "epidemiology", "metabolism"], "DescriptorName": "Influenza, Human"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Quercetin"}, {"QualifierName": ["metabolism"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Rajasekaran D., Palombo E.A., Yeo T.C., Ley D.L.S., Tu C.L., Malherbe F., Grollo L. Identification of Traditional Medicinal Plant Extracts with Novel Anti-Influenza Activity. PLoS ONE. 2013;8:e79293. doi: 10.1371/journal.pone.0079293.", "ArticleIdList": ["10.1371/journal.pone.0079293", "PMC3842314", "24312177"]}, {"Citation": "Bouvier N.M., Palese P. The biology of influenza viruses. Vaccine. 2008;26:D49\u2013D53. doi: 10.1016/j.vaccine.2008.07.039.", "ArticleIdList": ["10.1016/j.vaccine.2008.07.039", "PMC3074182", "19230160"]}, {"Citation": "Palese P., Shaw M. Orthomyxoviridae: The Viruses and their Replication. Fields Virol. 2007;26:1647\u20131689."}, {"Citation": "WHO . The Weekly Epidemiological Record. WHO; Geneva, Switzerland: 2012. Vaccines against Influenza; pp. 461\u2013476. WHO Position Paper\u2014November 2012.", "ArticleIdList": ["0"]}, {"Citation": "Iuliano A.D., Roguski K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., Cohen C., Gran J.M., Schanzer D., Cowling B.J., et al. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study. Lancet. 2018;391:1285\u20131300. doi: 10.1016/S0140-6736(17)33293-2.", "ArticleIdList": ["10.1016/S0140-6736(17)33293-2", "PMC5935243", "29248255"]}, {"Citation": "Macias A.E., McElhaney J., Chaves S.S., Nealon J., Nunes M.C., Samson S.I., Seet B.T., Weinke T., Yu H. The disease burden of influenza beyond respiratory illness. Vaccine. 2020:264. doi: 10.1016/j.vaccine.2020.09.048.", "ArticleIdList": ["10.1016/j.vaccine.2020.09.048", "PMC7545338", "33041103"]}, {"Citation": "Mehrbod P., Ande S.R., Alizadeh J., Rahimizadeh S., Shariati A., Malek H., Hashemi M., Glover K.K.M., Sher A.A., Coombs K.M., et al. The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence. 2019;10:376\u2013413. doi: 10.1080/21505594.2019.1605803.", "ArticleIdList": ["10.1080/21505594.2019.1605803", "PMC6527025", "30966844"]}, {"Citation": "Putri W.C., Muscatello D.J., Stockwell M.S., Newall A. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36:3960\u20133966. doi: 10.1016/j.vaccine.2018.05.057.", "ArticleIdList": ["10.1016/j.vaccine.2018.05.057", "29801998"]}, {"Citation": "Khorramdelazad H., Kazemi M.H., Najafi A., Keykhaee M., Emameh R.Z., Falak R. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microb. Pathog. 2020:104554. doi: 10.1016/j.micpath.2020.104554.", "ArticleIdList": ["10.1016/j.micpath.2020.104554", "PMC7607235", "33157216"]}, {"Citation": "Ding Q., Lu P., Fan Y., Xia Y., Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J. Med. Virol. 2020;92:1549\u20131555. doi: 10.1002/jmv.25781.", "ArticleIdList": ["10.1002/jmv.25781", "PMC7228290", "32196707"]}, {"Citation": "Ge W., Jingdong M., Jialun G., Yang S., Yue W., Dan F., Muru W., De-an T., Peiyuan L. Is Co-Infection with Influenza Virus a Protective Factor of COVID-19? Lancet Infect. Dis. 2020 doi: 10.2139/ssrn.3576904.", "ArticleIdList": ["10.2139/ssrn.3576904"]}, {"Citation": "Zhang A.J., Chan J.F., Liu F., Li C., Chen Y., Chu H., Lau S.Y., Wang P., Chan C.C., Poon V.K., et al. Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters. Clin. Infect. Dis. 2020:ciaa1747. doi: 10.1093/cid/ciaa1747.", "ArticleIdList": ["10.1093/cid/ciaa1747", "PMC7717201", "33216851"]}, {"Citation": "Drake T., Ho A., Turtle L., Russell C., Harrison E., Semple C. Influenza Infection in Patients Hospitalized with COVID-19: Rapid Report from CO-CIN Data; Proceedings of the 59 SAGE Meeting; London, UK. 24 September 2020."}, {"Citation": "Hayden F.G. Respiratory viral threats. Curr. Opin. Infect. Dis. 2006;19:169\u2013178. doi: 10.1097/01.qco.0000216628.51563.b1.", "ArticleIdList": ["10.1097/01.qco.0000216628.51563.b1", "16514342"]}, {"Citation": "Soema P.C., Kompier R., Amorij J.-P., Kersten G.F. Current and next generation influenza vaccines: Formulation and production strategies. Eur. J. Pharm. Biopharm. 2015;94:251\u2013263. doi: 10.1016/j.ejpb.2015.05.023.", "ArticleIdList": ["10.1016/j.ejpb.2015.05.023", "26047796"]}, {"Citation": "Barik S. New treatments for influenza. BMC Med. 2012;10:104. doi: 10.1186/1741-7015-10-104.", "ArticleIdList": ["10.1186/1741-7015-10-104", "PMC3523090", "22973873"]}, {"Citation": "Meijer A., Rebelo-De-Andrade H., Correia V., Besselaar T., Drager-Dayal R., Fry A., Gregory V., Gubareva L.V., Kageyama T., Lackenby A., et al. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012\u20132013. Antivir. Res. 2014;110:31\u201341. doi: 10.1016/j.antiviral.2014.07.001.", "ArticleIdList": ["10.1016/j.antiviral.2014.07.001", "PMC8851378", "25043638"]}, {"Citation": "WHO  . Global Influenza Strategy 2019\u20132030. WHO; Geneva, Switzerland: 2019.  [(accessed on 20 June 2020)].  Weekly Prevention, Control and Preparation 2019. Available online:  https://apps.who.int/iris/handle/10665/311184."}, {"Citation": "Fedson D.S. Confronting an influenza pandemic with inexpensive generic agents: Can it be done? Lancet Infect. Dis. 2008;8:571\u2013576. doi: 10.1016/S1473-3099(08)70070-7.", "ArticleIdList": ["10.1016/S1473-3099(08)70070-7", "PMC7128266", "18420459"]}, {"Citation": "Rodriguez W.J., Hall C.B., Welliver R., Simoes E.A.F., Ryan M.E., Stutman H., Johnson G., Van Dyke R., Groothuis J.R., Arrobio J., et al. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: A double-blind, multicenter, placebo-controlled trial. J. Pediatr. 1994;125:129\u2013135. doi: 10.1016/S0022-3476(94)70139-3.", "ArticleIdList": ["10.1016/S0022-3476(94)70139-3", "8021762"]}, {"Citation": "Gubareva L.V., Webster R.G., Hayden F.G. Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants. Antimicrob. Agents Chemother. 2001;45:3403\u20133408. doi: 10.1128/AAC.45.12.3403-3408.2001.", "ArticleIdList": ["10.1128/AAC.45.12.3403-3408.2001", "PMC90844", "11709315"]}, {"Citation": "Treanor J.J., Hayden F.G., Vrooman P.S., Barbarash R., Bettis R., Riff D., Singh S., Kinnersley N., Ward P., Mills R.G. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza\u2014A randomized controlled trial. J. Am. Med. Assoc. 2000;283:1016\u20131024. doi: 10.1001/jama.283.8.1016.", "ArticleIdList": ["10.1001/jama.283.8.1016", "10697061"]}, {"Citation": "Intharathep P., Laohpongspaisan C., Rungrotmongkol T., Loisruangsin A., Malaisree M., Decha P., Aruksakunwong O., Chuenpennit K., Kaiyawet N., Sompornpisut P., et al. How amantadine and rimantadine inhibit proton transport in the M2 protein channel. J. Mol. Graph. Model. 2008;27:342\u2013348. doi: 10.1016/j.jmgm.2008.06.002.", "ArticleIdList": ["10.1016/j.jmgm.2008.06.002", "18620883"]}, {"Citation": "Bouvier N.M., Lowen A.C., Palese P. Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol. J. Virol. 2008;82:10052\u201310058. doi: 10.1128/JVI.01226-08.", "ArticleIdList": ["10.1128/JVI.01226-08", "PMC2566271", "18684820"]}, {"Citation": "Bouvier N.M., Rahmat S., Pica N. Enhanced Mammalian Transmissibility of Seasonal Influenza A/H1N1 Viruses Encoding an Oseltamivir-Resistant Neuraminidase. J. Virol. 2012;86:7268\u20137279. doi: 10.1128/JVI.07242-12.", "ArticleIdList": ["10.1128/JVI.07242-12", "PMC3416348", "22532693"]}, {"Citation": "Ginting T.E., Shinya K., Kyan Y., Makino A., Matsumoto N., Kaneda S., Kawaoka Y. Amino acid changes in hemagglutinin contribute to the replication of Ooeltamivir-resistant H1N1 influenza viruses. J. Virol. 2012;86:121\u2013127. doi: 10.1128/JVI.06085-11.", "ArticleIdList": ["10.1128/JVI.06085-11", "PMC3255889", "22013054"]}, {"Citation": "Hussain M., Galvin H.D., Haw T.Y., Nutsford A.N., Husain M. Drug resistance in influenza A virus: The epidemiology and management. Infect. Drug Resist. 2017;10:121\u2013134. doi: 10.2147/IDR.S105473.", "ArticleIdList": ["10.2147/IDR.S105473", "PMC5404498", "28458567"]}, {"Citation": "Lampejo T. Influenza and antiviral resistance: An overview. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:1201\u20131208. doi: 10.1007/s10096-020-03840-9.", "ArticleIdList": ["10.1007/s10096-020-03840-9", "PMC7223162", "32056049"]}, {"Citation": "Yeganeh B., Ghavami S., Kroeker A.L., Mahood T.H., Stelmack G.L., Klonisch T., Coombs K.M., Halayko A.J. Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1. Am. J. Physiol. Cell. Mol. Physiol. 2015;308:L270\u2013L286. doi: 10.1152/ajplung.00011.2014.", "ArticleIdList": ["10.1152/ajplung.00011.2014", "PMC4338931", "25361566"]}, {"Citation": "Yeganeh B., Moghadam A.R., Tran A.T., Rahim M.N., Ande S.R., Hashemi M., Coombs K.M., Ghavami S. Asthma and influenza virus infection:focusing on cell death and stress pathways in influenza virus replication. Iran. J. Allergy Asthma Immunol. 2013;12:1\u201317.", "ArticleIdList": ["23454774"]}, {"Citation": "Wang J. Radiology of Influenza: A Practical Approach. Springer; Dordrecht, The Netherlands: 2016. Pathogenesis of Influenza; p. 9."}, {"Citation": "Fukuyama S., Kawaoka Y. The pathogenesis of influenza virus infections: The contributions of virus and host factors. Curr. Opin. Immunol. 2011;23:481\u2013486. doi: 10.1016/j.coi.2011.07.016.", "ArticleIdList": ["10.1016/j.coi.2011.07.016", "PMC3163725", "21840185"]}, {"Citation": "Oda T., Akaike T., Hamamoto T., Suzuki F., Hirano T., Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science. 1989;244:974\u2013976. doi: 10.1126/science.2543070.", "ArticleIdList": ["10.1126/science.2543070", "2543070"]}, {"Citation": "Buffinton G.D., Christen S., Peterhans E., Stocker R. Oxidative Stress in Lungs of Mice Infected with Influenza a Virus. Free Radic. Res. Commun. 1992;16:99\u2013110. doi: 10.3109/10715769209049163.", "ArticleIdList": ["10.3109/10715769209049163", "1321077"]}, {"Citation": "Schwarz K.B. Oxidative stress during viral infection: A review. Free. Radic. Biol. Med. 1996;21:641\u2013649. doi: 10.1016/0891-5849(96)00131-1.", "ArticleIdList": ["10.1016/0891-5849(96)00131-1", "8891667"]}, {"Citation": "Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y.M., Dietzschold B., Maeda H. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA. 1996;93:2448\u20132453. doi: 10.1073/pnas.93.6.2448.", "ArticleIdList": ["10.1073/pnas.93.6.2448", "PMC39817", "8637894"]}, {"Citation": "Peterhans E. Oxidants and Antioxidants in Viral Diseases: Disease Mechanisms and Metabolic Regulation. J. Nutr. 1997;127:962S\u2013965S. doi: 10.1093/jn/127.5.962S.", "ArticleIdList": ["10.1093/jn/127.5.962S", "9164274"]}, {"Citation": "Murphy A.W., Platts-Mills T.A., Lobo M., Hayden F. Respiratory nitric oxide levels in experimental human influenza. Chest. 1998;114:452\u2013456. doi: 10.1378/chest.114.2.452.", "ArticleIdList": ["10.1378/chest.114.2.452", "9726729"]}, {"Citation": "Cox N.J., Hughes J.M. New Options for the Prevention of Influenza. N. Engl. J. Med. 1999;341:1387\u20131388. doi: 10.1056/NEJM199910283411809.", "ArticleIdList": ["10.1056/NEJM199910283411809", "10536132"]}, {"Citation": "Han S.N., Meydani S.N. Antioxidants, Cytokines, and Influenza Infection in Aged Mice and Elderly Humans. J. Infect. Dis. 2000;182:S74\u2013S80. doi: 10.1086/315915.", "ArticleIdList": ["10.1086/315915", "10944487"]}, {"Citation": "De Maeyer E., De Maeyer-Guignard J. The Cytokine Handbook. Academic Press; London, UK: 1994. Interferons; pp. 265\u2013288."}, {"Citation": "Samuel C.E. Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 1991;183:1\u201311. doi: 10.1016/0042-6822(91)90112-O.", "ArticleIdList": ["10.1016/0042-6822(91)90112-O", "1711253"]}, {"Citation": "Pavlovic J., Haller O., Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 1992;66:2564\u20132569. doi: 10.1128/JVI.66.4.2564-2569.1992.", "ArticleIdList": ["10.1128/JVI.66.4.2564-2569.1992", "PMC289059", "1548781"]}, {"Citation": "Tough D.F., Borrow P., Sprent J. Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo. Science. 1996;272:1947\u20131950. doi: 10.1126/science.272.5270.1947.", "ArticleIdList": ["10.1126/science.272.5270.1947", "8658169"]}, {"Citation": "Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-\u03b3. Annu. Rev. Immunol. 1997;15:749\u2013795. doi: 10.1146/annurev.immunol.15.1.749.", "ArticleIdList": ["10.1146/annurev.immunol.15.1.749", "9143706"]}, {"Citation": "Marrack P., Kappler J. Subversion of the immune system by pathogens. Cell. 1994;76:323\u2013332. doi: 10.1016/0092-8674(94)90339-5.", "ArticleIdList": ["10.1016/0092-8674(94)90339-5", "8293466"]}, {"Citation": "Epstein F.H., Dinarello C.A., Wolff S.M. The Role of Interleukin-1 in Disease. N. Engl. J. Med. 1993;328:106\u2013113. doi: 10.1056/NEJM199301143280207.", "ArticleIdList": ["10.1056/NEJM199301143280207", "8439348"]}, {"Citation": "Zhang M., Tracey K. Tumor Necrosis Factor. Academic Press; San Diego, CA, USA: 1998. Cytokine Handbook; pp. 517\u2013548."}, {"Citation": "Van Campen H. Influenza A virus replication is inhibited by tumor necrosis factor-\u03b1 in vitro. Arch. Virol. 1994;136:439\u2013446. doi: 10.1007/BF01321073.", "ArticleIdList": ["10.1007/BF01321073", "8031247"]}, {"Citation": "Snapper C.M. The cytokine handbook. Immunol. Today. 1992;13:466\u2013467. doi: 10.1016/0167-5699(92)90082-I.", "ArticleIdList": ["10.1016/0167-5699(92)90082-I"]}, {"Citation": "Jacoby D.B. Virus-Induced Asthma Attacks. JAMA. 2002;287:755. doi: 10.1001/jama.287.6.755.", "ArticleIdList": ["10.1001/jama.287.6.755", "11851543"]}, {"Citation": "Ji C., Rouzer C.A., Marnett L.J., Pietenpol J.A. Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis. 1998;19:1275\u20131283. doi: 10.1093/carcin/19.7.1275.", "ArticleIdList": ["10.1093/carcin/19.7.1275", "9683189"]}, {"Citation": "Kakishita H., Hattori Y. Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sci. 2001;69:689\u2013697. doi: 10.1016/S0024-3205(01)01166-3.", "ArticleIdList": ["10.1016/S0024-3205(01)01166-3", "11476190"]}, {"Citation": "Palamara A.T., Nencioni L., Aquilano K., De Chiara G., Hernandez L., Cozzolino F., Ciriolo M.R., Garaci E. Inhibition of Influenza A Virus Replication by Resveratrol. J. Infect. Dis. 2005;191:1719\u20131729. doi: 10.1086/429694.", "ArticleIdList": ["10.1086/429694", "15838800"]}, {"Citation": "Fraternale A., Paoletti M.F., Casabianca A., Oiry J., Clayette P., Vogel J.-U., Cinatl J.J., Palamara A.T., Sgarbanti R., Garaci E., et al. Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules. Curr. Med. Chem. 2006;13:1749\u20131755. doi: 10.2174/092986706777452542.", "ArticleIdList": ["10.2174/092986706777452542", "16787218"]}, {"Citation": "Akhand A.A., Du J., Liu W., Hossain K., Miyata T., Nagase F., Kato M., Suzuki H., Nakashima I. Redox-Linked Cell Surface-Oriented Signaling for T-Cell Death. Antioxid. Redox Signal. 2002;4:445\u2013454. doi: 10.1089/15230860260196236.", "ArticleIdList": ["10.1089/15230860260196236", "12215211"]}, {"Citation": "Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 1997;15:351\u2013369. doi: 10.1146/annurev.immunol.15.1.351.", "ArticleIdList": ["10.1146/annurev.immunol.15.1.351", "9143692"]}, {"Citation": "Saladino R., Barontini M., Crucianelli M., Nencioni L., Sgarbanti R., Palamara A.T. Current advances in anti-influenza therapy. Curr. Med. Chem. 2010;17:2101\u20132140. doi: 10.2174/092986710791299957.", "ArticleIdList": ["10.2174/092986710791299957", "20423307"]}, {"Citation": "Liu B., Mori I., Hossain J., Dong L., Chen Z., Kimura Y. Local immune responses to influenza virus infection in mice with a targeted disruption of perforin gene. Microb. Pathog. 2003;34:161\u2013167. doi: 10.1016/S0882-4010(02)00191-2.", "ArticleIdList": ["10.1016/S0882-4010(02)00191-2", "12668139"]}, {"Citation": "Mileva M., Bakalova R., Tancheva L., Galabov S. Effect of immobilization, cold and cold-restraint stress on liver monooxygenase activity and lipid peroxidation of influenza virus-infected mice. Arch. Toxicol. 2002;76:96\u2013103. doi: 10.1007/s00204-001-0306-6.", "ArticleIdList": ["10.1007/s00204-001-0306-6", "11914779"]}, {"Citation": "Mileva M., Bakalova R., Tancheva L., Galabov A., Ribarov S. Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice. Comp. Immunol. Microbiol. Infect. Dis. 2002;25:1\u201311. doi: 10.1016/S0147-9571(01)00010-8.", "ArticleIdList": ["10.1016/S0147-9571(01)00010-8", "11831742"]}, {"Citation": "Valyi-Nagy T., Dermody T.S. Role of oxidative damage in the pathogenesis of viral infections of the nervous system. Histol. Histopathol. 2005;20:957\u2013967.", "ArticleIdList": ["15944946"]}, {"Citation": "Vlahos R., Stambas J., Selemidis S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol. Sci. 2012;33:3\u20138. doi: 10.1016/j.tips.2011.09.001.", "ArticleIdList": ["10.1016/j.tips.2011.09.001", "21962460"]}, {"Citation": "Mileva M. Oxidative stress as a target for medication of influenza virus infection. Acta Microbiol. Bulg. 2016;32:3\u20139."}, {"Citation": "Khalafalla M.M. Active principle from moringa oleifera Lam leaves effective against two leukemias and a hepatocarcinoma. Afr. J. Biotechnol. 2010;9:8467\u20138471."}, {"Citation": "Gurib-Fakim A., Brendler T., Philips L.D., Eloff J.N. Green Gold: Success Stories Using Southern African Medicinal Plant Species. AAMPS Publishing; Totnes, UK: 2010."}, {"Citation": "Lin L.-T., Hsu W.-C., Lin C.-C. Antiviral Natural Products and Herbal Medicines. J. Tradit. Complement. Med. 2014;4:24\u201335. doi: 10.4103/2225-4110.124335.", "ArticleIdList": ["10.4103/2225-4110.124335", "PMC4032839", "24872930"]}, {"Citation": "Aqil F., Ahmad I., Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turk. J. Biol. 2006;30:177\u2013183."}, {"Citation": "Karimi A., Majlesi M., Rafieian-Kopaei M. Herbal versus synthetic drugs; beliefs and facts. J. Nephropharmacol. 2015;4:27\u201330.", "ArticleIdList": ["PMC5297475", "28197471"]}, {"Citation": "Zink T., Chaffin J. Herbal \u2019health\u2019 products: What family physicians need to know. Am. Fam. Physician. 1998;58:1133\u20131140.", "ArticleIdList": ["9787279"]}, {"Citation": "Milugo T.K., Omosa L.K., Ochanda J., Owuor B., Wamunyokoli F., Oyugi J., Ochieng J.W. Antagonistic effect of alkaloids and saponins on bioactivity in the quinine tree (Rauvolfia caffra sond.): Further evidence to support biotechnology in traditional medicinal plants. BMC Complement. Altern. Med. 2013;13:285. doi: 10.1186/1472-6882-13-285.", "ArticleIdList": ["10.1186/1472-6882-13-285", "PMC3816308", "24160735"]}, {"Citation": "Palhares R.M., Drummond M.G., Brasil B.D.S.A.F., Cosenza G.P., Brand\u00e3o M.D.G.L., Oliveira G. Medicinal Plants Recommended by the World Health Organization: DNA Barcode Identification Associated with Chemical Analyses Guarantees Their Quality. PLoS ONE. 2015;10:e0127866. doi: 10.1371/journal.pone.0127866.", "ArticleIdList": ["10.1371/journal.pone.0127866", "PMC4433216", "25978064"]}, {"Citation": "Geldenhuys C., Mitchell D. Sustainable Harvesting Technologies in Commercialising Medicinal Plants\u2014A Southern African Guide. Sun Press; Stellenbosch, South Africa: 2006."}, {"Citation": "Street R.A., Prinsloo G. Commercially Important Medicinal Plants of South Africa: A Review. J. Chem. 2013;2013:1\u201316. doi: 10.1155/2013/205048.", "ArticleIdList": ["10.1155/2013/205048"]}, {"Citation": "Gansukh E., Muthu M., Paul D., Ethiraj G., Chun S., Gopal J. Nature nominee quercetin\u2019s anti-influenza combat strategy-Demonstrations and remonstrations. Rev. Med. Virol. 2017;27:e1930. doi: 10.1002/rmv.1930.", "ArticleIdList": ["10.1002/rmv.1930", "31211498"]}, {"Citation": "Parasuraman S., David A.V.A., Arulmoli R. Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn. Rev. 2016;10:84\u201389. doi: 10.4103/0973-7847.194044.", "ArticleIdList": ["10.4103/0973-7847.194044", "PMC5214562", "28082789"]}, {"Citation": "Chun O.K., Chung S.-J., Claycombe K.J., Song W.O. Serum C-Reactive Protein Concentrations Are Inversely Associated with Dietary Flavonoid Intake in U.S. Adults. J. Nutr. 2008;138:753\u2013760. doi: 10.1093/jn/138.4.753.", "ArticleIdList": ["10.1093/jn/138.4.753", "18356331"]}, {"Citation": "Mehrbod P., Abdalla M.A., Fotouhi F., Heidarzadeh M., Aro A.O., Eloff J.N., McGaw L.J., Fasina F.O. Immunomodulatory properties of quercetin-3-O-\u03b1-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus. BMC Complement. Altern. Med. 2018;18:184. doi: 10.1186/s12906-018-2246-1.", "ArticleIdList": ["10.1186/s12906-018-2246-1", "PMC6003079", "29903008"]}, {"Citation": "Lin C.-F., Leu Y.-L., Al-Suwayeh S.A., Ku M.-C., Hwang T.-L., Fang J.-Y. Anti-inflammatory activity and percutaneous absorption of quercetin and its polymethoxylated compound and glycosides: The relationships to chemical structures. Eur. J. Pharm. Sci. 2012;47:857\u2013864. doi: 10.1016/j.ejps.2012.04.024.", "ArticleIdList": ["10.1016/j.ejps.2012.04.024", "22609526"]}, {"Citation": "Delgado L., Fernandes I., Gonz\u00e1lez-Manzano S., De Freitas V., Mateus N., Santos-Buelga C. Anti-proliferative effects of quercetin and catechin metabolites. Food Funct. 2014;5:797. doi: 10.1039/c3fo60441a.", "ArticleIdList": ["10.1039/c3fo60441a", "24573487"]}, {"Citation": "Gansukh E., Kazibwe Z., Pandurangan M., Judy G., Kim D.H. Probing the impact of quercetin-7-O-glucoside on influenza virus replication influence. Phytomedicine. 2016;23:958\u2013967. doi: 10.1016/j.phymed.2016.06.001.", "ArticleIdList": ["10.1016/j.phymed.2016.06.001", "27387404"]}, {"Citation": "Li M.Y., Xu Z. Quercetin in a lotus leaves extract may be responsible for antibacterial activity. Arch. Pharmacal Res. 2008;31:640\u2013644. doi: 10.1007/s12272-001-1206-5.", "ArticleIdList": ["10.1007/s12272-001-1206-5", "18481022"]}, {"Citation": "Atashpour S., Fouladdel S., Movahhed T.K., Barzegar E., Ghahremani M.H., Ostad S.N., Azizi E. Quercetin induces cell cycle arrest and apoptosis in CD133+ cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin. Iran J. Basic Med. Sci. 2015;18:635\u2013643.", "ArticleIdList": ["PMC4556754", "26351552"]}, {"Citation": "Dajas F. Life or death: Neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 2012;143:383\u2013396. doi: 10.1016/j.jep.2012.07.005.", "ArticleIdList": ["10.1016/j.jep.2012.07.005", "22820241"]}, {"Citation": "Yu B., Liu Y.-H., Yu B., Wang Z.-Y., Zang J.-N., Yu C. Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food Chem. Toxicol. 2013;52:53\u201360. doi: 10.1016/j.fct.2012.10.030.", "ArticleIdList": ["10.1016/j.fct.2012.10.030", "23123425"]}, {"Citation": "Choi H.J., Song J.H., Park K.S., Kwon D.-H. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur. J. Pharm. Sci. 2009;37:329\u2013333. doi: 10.1016/j.ejps.2009.03.002.", "ArticleIdList": ["10.1016/j.ejps.2009.03.002", "19491023"]}, {"Citation": "Mehrbod P., Ebrahimi S.N., Fotouhi F., Eskandari F., Eloff J.N., McGaw L., Fasina F.O. Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-\u03b1-L-rhamnopyranoside from indigenous south African medicinal plant Rapanea melanophloeos. BMC Complement. Altern. Med. 2019;19:1\u201311. doi: 10.1186/s12906-019-2774-3.", "ArticleIdList": ["10.1186/s12906-019-2774-3", "PMC6888925", "31791311"]}, {"Citation": "Murota K., Terao J. Antioxidative flavonoid quercetin: Implications of its intenstinal absorption and metabolism. Arch. Biochem. Biophys. 2003;417:12\u201317. doi: 10.1016/S0003-9861(03)00284-4.", "ArticleIdList": ["10.1016/S0003-9861(03)00284-4", "12921774"]}, {"Citation": "Dayem A.A., Choi H.Y., Kim Y.B., Cho S.-G. Antiviral Effect of Methylated Flavonol Isorhamnetin against Influenza. PLoS ONE. 2015;10:e0121610. doi: 10.1371/journal.pone.0121610.", "ArticleIdList": ["10.1371/journal.pone.0121610", "PMC4373826", "25806943"]}, {"Citation": "Pawlikowska-Pawl\u0119ga B., Gruszecki W.I., Misiak L., Paduch R., Piersiak T., Zarzyka B., Pawelec J., Gawron A. Modification of membranes by quercetin, a naturally occurring flavonoid, via its incorporation in the polar head group. Biochim. Biophys. Acta Biomembr. 2007;1768:2195\u20132204. doi: 10.1016/j.bbamem.2007.05.027.", "ArticleIdList": ["10.1016/j.bbamem.2007.05.027", "17632074"]}, {"Citation": "Albuquerque U.P., De Medeiros P.M., De Almeida A.L.S., Monteiro J.M., Neto E.M.D.F.L., De Melo J.G., Dos Santos J.P. Medicinal plants of the caatinga (semi-arid) vegetation of NE Brazil: A quantitative approach. J. Ethnopharmacol. 2007;114:325\u2013354. doi: 10.1016/j.jep.2007.08.017.", "ArticleIdList": ["10.1016/j.jep.2007.08.017", "17900836"]}, {"Citation": "De Almeida C., Silva T.D.L.E., De Amorim E., Maia M.D.S., De Albuquerque U.P. Life strategy and chemical composition as predictors of the selection of medicinal plants from the caatinga (Northeast Brazil) J. Arid. Environ. 2005;62:127\u2013142. doi: 10.1016/j.jaridenv.2004.09.020.", "ArticleIdList": ["10.1016/j.jaridenv.2004.09.020"]}, {"Citation": "Luz L.D.R., Porto D.D., Castro C.B., Silva M.F.S., Filho E.D.G.A., Canuto K.M., De Brito E.S., Becker H., Pessoa C.D.\u00d3., Zocolo G.J. Metabolomic profile of Schinopsis brasiliensis via UPLC-QTOF-MS for identification of biomarkers and evaluation of its cytotoxic potential. J. Chromatogr. B. 2018;1099:97\u2013109. doi: 10.1016/j.jchromb.2018.09.019.", "ArticleIdList": ["10.1016/j.jchromb.2018.09.019", "30265941"]}, {"Citation": "Ding F., Liu J., Du R., Yu Q., Gong L., Jiang H., Rong R. Qualitative and Quantitative Analysis for the Chemical Constituents of Tetrastigma hemsleyanum Diels et Gilg Using Ultra-High Performance Liquid Chromatography/Hybrid Quadrupole-Orbitrap Mass Spectrometry and Preliminary Screening for Anti-Influenza Virus Components. Evid. Based Complement. Altern. Med. 2019;2019:9414926. doi: 10.1155/2019/9414926.", "ArticleIdList": ["10.1155/2019/9414926", "PMC6398048", "30906418"]}, {"Citation": "Kim Y., Narayanan S., Chang K.-O. Inhibition of influenza virus replication by plant-derived isoquercetin. Antivir. Res. 2010;88:227\u2013235. doi: 10.1016/j.antiviral.2010.08.016.", "ArticleIdList": ["10.1016/j.antiviral.2010.08.016", "20826184"]}, {"Citation": "Ibrahim A.K., Youssef A.I., Arafa A.S., Ahmed S. Anti-H5N1 virus flavonoids fromCapparis sinaicaVeill. Nat. Prod. Res. 2013;27:2149\u20132153. doi: 10.1080/14786419.2013.790027.", "ArticleIdList": ["10.1080/14786419.2013.790027", "23651316"]}, {"Citation": "Yang Z., Bai L., Huang W.-B., Li X.-Z., Zhao S.-S., Zhong N., Jiang Z. Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure\u2013activity relationship analysis. Fitoterapia. 2014;93:47\u201353. doi: 10.1016/j.fitote.2013.12.011.", "ArticleIdList": ["10.1016/j.fitote.2013.12.011", "24370660"]}, {"Citation": "Sekizawa H., Ikuta K., Ohnishi-Kameyama M., Nishiyama K., Suzutani T. Identification of the Components in a Vaccinium oldhamii Extract Showing Inhibitory Activity against Influenza Virus Adsorption. Foods. 2019;8:172. doi: 10.3390/foods8050172.", "ArticleIdList": ["10.3390/foods8050172", "PMC6560511", "31137514"]}, {"Citation": "Thapa M., Kim Y., Desper J., Chang K.-O., Hua D.H. Synthesis and antiviral activity of substituted quercetins. Bioorg. Med. Chem. Lett. 2012;22:353\u2013356. doi: 10.1016/j.bmcl.2011.10.119.", "ArticleIdList": ["10.1016/j.bmcl.2011.10.119", "PMC3249009", "22115591"]}, {"Citation": "Liu A., Wang H.-D., Lee S.M.-Y., Wang Y.-T., Du G. Structure\u2013activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg. Med. Chem. 2008;16:7141\u20137147. doi: 10.1016/j.bmc.2008.06.049.", "ArticleIdList": ["10.1016/j.bmc.2008.06.049", "18640042"]}, {"Citation": "Karimova E., Baltina L., Spirikhin L., Gabbasov T., Orshanskaya Y., Zarubaev V. Synthesis and Antiviral Activity of Quercetin Brominated Derivatives. Nat. Prod. Commun. 2015;10:1565\u20131568. doi: 10.1177/1934578X1501000920.", "ArticleIdList": ["10.1177/1934578X1501000920", "26594760"]}, {"Citation": "Lall N., Hussein A., Meyer J. Antiviral and antituberculous activity of Helichrysum melanacme constituents. Fitoterapia. 2006;77:230\u2013232. doi: 10.1016/j.fitote.2006.01.007.", "ArticleIdList": ["10.1016/j.fitote.2006.01.007", "16529879"]}, {"Citation": "Vasas A., Orb\u00e1n-Gyapai O., Hohmann J. The Genus Rumex: Review of traditional uses, phytochemistry and pharmacology. J. Ethnopharmacol. 2015;175:198\u2013228. doi: 10.1016/j.jep.2015.09.001.", "ArticleIdList": ["10.1016/j.jep.2015.09.001", "26384001"]}, {"Citation": "El-Kashak W.A., ElShamy A.I., Mohamed T.A., Farag M.A., Saleh I.A., Umeyama A. Rumpictuside A: Unusual 9,10-anthraquinone glucoside from Rumex pictus Forssk. Carbohydr. Res. 2017;448:74\u201378. doi: 10.1016/j.carres.2017.05.023.", "ArticleIdList": ["10.1016/j.carres.2017.05.023", "28623737"]}, {"Citation": "Eropkin M.I., Gudkova T.M., Konovalova N., Shchekanova S.M., Iaglovskaia I.B., Eropkina E.M., Kiselev O. Antiviral action of some antioxidants/antihypoxants and their combinations with remantadine against human influenza A(H3N2) virus studied in in vitro models. Exp. Clin. Farmacol. 2007;70:33\u201337.", "ArticleIdList": ["18074805"]}, {"Citation": "Bertelli A., Mannari C., Santi S., Filippi C., Migliori M., Giovannini L. Immunomodulatory activity of shikimic acid and quercitin in comparison with oseltamivir (Tamiflu) in an \u201cin vitro\u201d model. J. Med. Virol. 2008;80:741\u2013745. doi: 10.1002/jmv.21072.", "ArticleIdList": ["10.1002/jmv.21072", "18297698"]}, {"Citation": "Xu L., Kelvin D.J., Ye G.Q., Taub D.D., Ben-Baruch A., Oppenheim J.J., Wang J.M. Modulation of IL-8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL-8. J. Leukoc. Biol. 1995;57:335\u2013342. doi: 10.1002/jlb.57.2.335.", "ArticleIdList": ["10.1002/jlb.57.2.335", "7852848"]}, {"Citation": "Huber A., Kunkel S., Todd R., Weiss S. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991;254:99\u2013102. doi: 10.1126/science.1718038.", "ArticleIdList": ["10.1126/science.1718038", "1718038"]}, {"Citation": "Tsan M.F., White J., Del Vecchio P.J., Shaffer J.B. IL-6 enhances TNF-alpha- and IL-1-induced increase of Mn superoxide dismutase mRNA and O2 tolerance. Am. J. Physiol. Content. 1992;263:22. doi: 10.1152/ajplung.1992.263.1.L22.", "ArticleIdList": ["10.1152/ajplung.1992.263.1.L22", "1636726"]}, {"Citation": "Zhang L., Cheng Y.-X., Liu A.-L., Wang H.-D., Wang Y.-L., Du G.-H. Antioxidant, Anti-Inflammatory and Anti-Influenza Properties of Components from Chaenomeles speciosa. Molecules. 2010;15:8507\u20138517. doi: 10.3390/molecules15118507.", "ArticleIdList": ["10.3390/molecules15118507", "PMC6259204", "21102377"]}, {"Citation": "Cho W.-K., Weeratunga P., Lee B.-H., Park J.-S., Kim C.-J., Ma J.Y., Lee J.-S. Epimedium koreanum Nakai Displays Broad Spectrum of Antiviral Activity in Vitro and in Vivo by Inducing Cellular Antiviral State. Viruses. 2015;7:352\u2013377. doi: 10.3390/v7010352.", "ArticleIdList": ["10.3390/v7010352", "PMC4306843", "25609307"]}, {"Citation": "Choi J.-G., Lee H., Hwang Y.-H., Lee J.-S., Cho W.-K., Ma J.Y. Eupatorium fortunei and Its Components Increase Antiviral Immune Responses against RNA Viruses. Front. Pharmacol. 2017;8:511. doi: 10.3389/fphar.2017.00511.", "ArticleIdList": ["10.3389/fphar.2017.00511", "PMC5541272", "28824435"]}, {"Citation": "Mehrbod P., Abdalla M.A., Njoya E.M., Ahmed A.S., Fotouhi F., Farahmand B., Gado D.A., Tabatabaian M., Fasanmi O.G., Eloff J.N., et al. South African medicinal plant extracts active against influenza A virus. BMC Complement. Altern. Med. 2018;18:112. doi: 10.1186/s12906-018-2184-y.", "ArticleIdList": ["10.1186/s12906-018-2184-y", "PMC5872571", "29587734"]}, {"Citation": "Donelan N.R., Basler C.F., Garcia-Sarstre A. A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice. J. Virol. 2003;77:13257\u201313266. doi: 10.1128/JVI.77.24.13257-13266.2003.", "ArticleIdList": ["10.1128/JVI.77.24.13257-13266.2003", "PMC296096", "14645582"]}, {"Citation": "Yeganeh B., Ghavami S., Rahim N., Klonisch T., Halayko A., Coombs K.M. Autophagy activation is required for influenza A virus-induced apoptosis and replication. Biochim. Biophys. Acta Mol. Cell Res. 2018;1865:364\u2013378. doi: 10.1016/j.bbamcr.2017.10.014.", "ArticleIdList": ["10.1016/j.bbamcr.2017.10.014", "29108912"]}, {"Citation": "Chen C., Jiang Z.-Y., Yu B., Wu X.-L., Dai C.-Q., Zhao C., Ju D.-H., Chen X. Study on the anti-H1N1 virus effects of quercetin and oseltamivir and their mechanism related to TLR7 pathway. J. Asian Nat. Prod. Res. 2012;14:877\u2013885. doi: 10.1080/10286020.2012.702108.", "ArticleIdList": ["10.1080/10286020.2012.702108", "22924574"]}, {"Citation": "Wan Q., Wang H., Lin Y., Gu L., Han M., Yang Z., Zhang Y., Ma R., Wang L., Wang Z. Effects of quercetin on CDK4 mRNA and protein expression in A549 cells infected by H1N1. Biomed. Rep. 2013;1:766\u2013770. doi: 10.3892/br.2013.141.", "ArticleIdList": ["10.3892/br.2013.141", "PMC3917044", "24649026"]}, {"Citation": "Cheng J., Ohsaki Y., Tauchi-Sato K., Fujita A., Fujimoto T. Cholesterol depletion induces autophagy. Biochem. Biophys. Res. Commun. 2006;351:246\u2013252. doi: 10.1016/j.bbrc.2006.10.042.", "ArticleIdList": ["10.1016/j.bbrc.2006.10.042", "17056010"]}, {"Citation": "Gannag\u00e9 M., Dormann D., Albrecht R., Dengjel J., Torossi T., R\u00e4mer P.C., Lee M., Strowig T., Arrey F., Conenello G., et al. Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes. Cell Host Microbe. 2009;6:367\u2013380. doi: 10.1016/j.chom.2009.09.005.", "ArticleIdList": ["10.1016/j.chom.2009.09.005", "PMC2774833", "19837376"]}, {"Citation": "Rossman J.S., Lamb R.A. Autophagy, Apoptosis, and the Influenza Virus M2 Protein. Cell Host Microbe. 2009;6:299\u2013300. doi: 10.1016/j.chom.2009.09.009.", "ArticleIdList": ["10.1016/j.chom.2009.09.009", "19837369"]}, {"Citation": "Das K., Aramini J.M., Ma L.-C., Krug R.M., Arnold E. Structures of influenza A proteins and insights into antiviral drug targets. Nat. Struct. Mol. Biol. 2010;17:530\u2013538. doi: 10.1038/nsmb.1779.", "ArticleIdList": ["10.1038/nsmb.1779", "PMC2957899", "20383144"]}, {"Citation": "Byrn R.A., Jones S.M., Bennett H.B., Bral C., Clark M.P., Jacobs M.D., Kwong A.D., Ledeboer M.W., Leeman J.R., McNeil C.F., et al. Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit. Antimicrob. Agents Chemother. 2015;59:1569\u20131582. doi: 10.1128/AAC.04623-14.", "ArticleIdList": ["10.1128/AAC.04623-14", "PMC4325764", "25547360"]}, {"Citation": "Jang K.S. Effects of various sub-ingredients on sensory quality of Korean cabbage kimchi. Korean J. Food Nutr. 1991;20:233\u2013240."}, {"Citation": "Vaidya B., Cho S.-Y., Oh K.-S., Kim S.H., Kim Y., Jeong E.-H., Nguyen T.T., Kim S.H., Kim I.S., Kwon J., et al. Effectiveness of Periodic Treatment of Quercetin against Influenza A Virus H1N1 through Modulation of Protein Expression. J. Agric. Food Chem. 2016;64:4416\u20134425. doi: 10.1021/acs.jafc.6b00148.", "ArticleIdList": ["10.1021/acs.jafc.6b00148", "27157719"]}, {"Citation": "Choi J.-G., Lee H., Kim Y.S., Hwang Y.-H., Oh Y.-C., Lee B., Moon K.M., Cho W.-K., Ma J.Y. Aloe vera and its Components Inhibit Influenza A Virus-Induced Autophagy and Replication. Am. J. Chin. Med. 2019;47:1307\u20131324. doi: 10.1142/S0192415X19500678.", "ArticleIdList": ["10.1142/S0192415X19500678", "31505936"]}, {"Citation": "Nejatzadeh-Barandozi F. Antibacterial activities and antioxidant capacity of Aloe vera. Org. Med. Chem. Lett. 2013;3:5. doi: 10.1186/2191-2858-3-5.", "ArticleIdList": ["10.1186/2191-2858-3-5", "PMC3729540", "23870710"]}, {"Citation": "Glatthaar-Saalm\u00fcller B., Fal A.M., Sch\u00f6nknecht K., Conrad F., Sievers H., Saalmuller A. Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract. Phytomedicine. 2015;22:911\u2013920. doi: 10.1016/j.phymed.2015.06.006.", "ArticleIdList": ["10.1016/j.phymed.2015.06.006", "PMC7127631", "26321740"]}, {"Citation": "Li S.-W., Yang T.-C., Lai C.-C., Huang S.-H., Liao J.-M., Wan L., Lin Y.-J., Lin C.-W. Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation. Eur. J. Pharmacol. 2014;738:125\u2013132. doi: 10.1016/j.ejphar.2014.05.028.", "ArticleIdList": ["10.1016/j.ejphar.2014.05.028", "24877694"]}, {"Citation": "L\u00f3pez-Exp\u00f3sito I., Castillo A., Yang N., Liang B., Li X.-M. Chinese herbal extracts of Rubia cordifolia and Dianthus superbus suppress IgE production and prevent peanut-induced anaphylaxis. Chin. Med. 2011;6:35. doi: 10.1186/1749-8546-6-35.", "ArticleIdList": ["10.1186/1749-8546-6-35", "PMC3204269", "21961957"]}, {"Citation": "Nile S.H., Kim D.H., Nile A., Park G.S., Gansukh E., Kai G. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- in vitro and in silico biochemical and toxicological screening. Food Chem. Toxicol. 2020;135:110985. doi: 10.1016/j.fct.2019.110985.", "ArticleIdList": ["10.1016/j.fct.2019.110985", "31765700"]}, {"Citation": "Rakers C., Schwerdtfeger S.-M., Mortier J., Duwe S., Wolff T., Wolber G., Melzig M.F. Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase. Bioorg. Med. Chem. Lett. 2014;24:4312\u20134317. doi: 10.1016/j.bmcl.2014.07.010.", "ArticleIdList": ["10.1016/j.bmcl.2014.07.010", "25096296"]}, {"Citation": "Duan J., Lou J., Zhang Q., Ke J., Qi Y., Shen N., Zhu B., Zhong R., Wang Z., Liu L., et al. A Genetic Variant rs1801274 in FCGR2A as a Potential Risk Marker for Kawasaki Disease: A Case-Control Study and Meta-Analysis. PLoS ONE. 2014;9:e103329. doi: 10.1371/journal.pone.0103329.", "ArticleIdList": ["10.1371/journal.pone.0103329", "PMC4122468", "25093412"]}, {"Citation": "Lee I.-K., Hwang B.S., Kim D.-W., Kim J.-Y., Woo E.-E., Lee Y.-J., Choi H.J., Yun B.-S. Characterization of Neuraminidase Inhibitors in Korean Papaver rhoeas Bee Pollen Contributing to Anti-Influenza Activities In Vitro. Planta Med. 2016;82:524\u2013529. doi: 10.1055/s-0041-111631.", "ArticleIdList": ["10.1055/s-0041-111631", "26848705"]}, {"Citation": "Graikou K., Kapeta S., Aligiannis N., Sotiroudis G., Chondrogianni N., Gonos E.S., Chinou I. Chemical analysis of Greek pollen\u2014Antioxidant, antimicrobial and proteasome activation properties. Chem. Cent. J. 2011;5:33. doi: 10.1186/1752-153X-5-33.", "ArticleIdList": ["10.1186/1752-153X-5-33", "PMC3135496", "21699688"]}, {"Citation": "Kim D.H., Park G.S., Nile A.S., Kwon Y.D., Gansukh E., Nile S.H. Utilization of Dianthus superbus L and its bioactive compounds for antioxidant, anti-influenza and toxicological effects. Food Chem. Toxicol. 2019;125:313\u2013321. doi: 10.1016/j.fct.2019.01.013.", "ArticleIdList": ["10.1016/j.fct.2019.01.013", "30654095"]}, {"Citation": "Liu Z., Zhao J., Li W., Wang X., Xu J., Xie J., Tao K., Shen L., Zhang R. Molecular Docking of Potential Inhibitors for Influenza H7N9. Comput. Math. Methods Med. 2015;2015:480764. doi: 10.1155/2015/480764.", "ArticleIdList": ["10.1155/2015/480764", "PMC4377397", "25861376"]}, {"Citation": "Liu Z., Zhao J., Li W., Shen L., Huang S., Tang J., Duan J., Fang F., Huang Y., Chang H., et al. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine. Sci. Rep. 2016;6:19095. doi: 10.1038/srep19095.", "ArticleIdList": ["10.1038/srep19095", "PMC4709578", "26754609"]}, {"Citation": "Yin J., Ma L., Wang H., Yan H., Huiqiang W., Jiang W., Li Y. Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of influenza virus infection through activation of heme oxygenase-1. Acta Pharm. Sin. B. 2017;7:630\u2013637. doi: 10.1016/j.apsb.2017.05.006.", "ArticleIdList": ["10.1016/j.apsb.2017.05.006", "PMC5687314", "29159022"]}, {"Citation": "Sadati S.M., Gheibi N., Ranjbar S., Hashemzadeh M.S. Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidase. Biomed. Rep. 2018;10:33\u201338. doi: 10.3892/br.2018.1173.", "ArticleIdList": ["10.3892/br.2018.1173", "PMC6299203", "30588301"]}, {"Citation": "Xu L., Jiang W., Jia H., Zheng L., Xing J., Liu A., Du G. Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions. Front. Cell. Infect. Microbiol. 2020;10:16. doi: 10.3389/fcimb.2020.00016.", "ArticleIdList": ["10.3389/fcimb.2020.00016", "PMC7026480", "32117796"]}, {"Citation": "Wu W., Li R., Li X., He J., Jiang S., Liu S., Yang J. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry. Viruses. 2015;8:6. doi: 10.3390/v8010006.", "ArticleIdList": ["10.3390/v8010006", "PMC4728566", "26712783"]}, {"Citation": "E\u015fanu V., Prahoveanu E., Cri\u015fan I., Cioca A. The effect of an aqueous propolis extract, of rutin and of a rutin-quercetin mixture on experimental influenza virus infection in mice. Virology. 1981;32:213\u2013215.", "ArticleIdList": ["7303493"]}, {"Citation": "Msc T.A.N.R., Lakshmi A.N.V., Anand T., Rao L.V., Sharma G. Protective effects of quercetin during influenza virus-induced oxidative stress. Asia Pac. J. Clin. Nutr. 2000;9:314\u2013317. doi: 10.1046/j.1440-6047.2000.00162.x.", "ArticleIdList": ["10.1046/j.1440-6047.2000.00162.x", "24394509"]}, {"Citation": "Kumar P., Sharma S., Khanna M., Raj H.G. Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. Int. J. Exp. Pathol. 2003;84:127\u2013134. doi: 10.1046/j.1365-2613.2003.00344.x.", "ArticleIdList": ["10.1046/j.1365-2613.2003.00344.x", "PMC2517549", "12974942"]}, {"Citation": "Kumar P., Khanna M., Srivastava V., Tyagi Y.K., Raj H.G., Ravi K. Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection. Exp. Lung Res. 2005;31:449\u2013459. doi: 10.1080/019021490927088.", "ArticleIdList": ["10.1080/019021490927088", "16019982"]}, {"Citation": "Savov V.M., Galabov A.S., Tantcheva L.P., Mileva M.M., Pavlova E., Stoeva E.S., Braykova A.A. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection. Exp. Toxicol. Pathol. 2006;58:59\u201364. doi: 10.1016/j.etp.2006.05.002.", "ArticleIdList": ["10.1016/j.etp.2006.05.002", "16793246"]}, {"Citation": "Chan M.C.W., Cheung C.Y., Chui W.H., Tsao G.S.-W., Nicholls J.M., Chan Y., Chan R.W.Y., Long H.T., Poon L.L.M., Guan Y., et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 2005;6:135. doi: 10.1186/1465-9921-6-135.", "ArticleIdList": ["10.1186/1465-9921-6-135", "PMC1318487", "16283933"]}, {"Citation": "Lee D.C.W., Cheung C.-Y., Law A.H.Y., Mok C.K.P., Peiris M., Lau A.S.Y. p38 Mitogen-Activated Protein Kinase-Dependent Hyperinduction of Tumor Necrosis Factor Alpha Expression in Response to Avian Influenza Virus H5N1. J. Virol. 2005;79:10147\u201310154. doi: 10.1128/JVI.79.16.10147-10154.2005.", "ArticleIdList": ["10.1128/JVI.79.16.10147-10154.2005", "PMC1182678", "16051807"]}, {"Citation": "Friel H., Lederman H. A nutritional supplement formula for influenza A (H5N1) infection in humans. Med. Hypotheses. 2006;67:578\u2013587. doi: 10.1016/j.mehy.2006.02.040.", "ArticleIdList": ["10.1016/j.mehy.2006.02.040", "16624496"]}, {"Citation": "Brown A.S., Davis J.M., Murphy E.A., Carmichael M.D., Ghaffar A., Mayer E.P. Gender Differences in Viral Infection after Repeated Exercise Stress. Med. Sci. Sports Exerc. 2004;36:1290\u20131295. doi: 10.1249/01.MSS.0000135798.72735.B3.", "ArticleIdList": ["10.1249/01.MSS.0000135798.72735.B3", "15292734"]}, {"Citation": "Brown A.S., Davis J.M., Murphy E.A., Carmichael M.D., Carson J., Ghaffar A., Mayer E.P. Susceptibility to HSV-1 infection and exercise stress in female mice: Role of estrogen. J. Appl. Physiol. 2007;103:1592\u20131597. doi: 10.1152/japplphysiol.00677.2007.", "ArticleIdList": ["10.1152/japplphysiol.00677.2007", "17823297"]}, {"Citation": "Davis J.M., Kohut M.L., Colbert L.H., Jackson D.A., Ghaffar A., Mayer E.P. Exercise, alveolar macrophage function, and susceptibility to respiratory infection. J. Appl. Physiol. 1997;83:1461\u20131466. doi: 10.1152/jappl.1997.83.5.1461.", "ArticleIdList": ["10.1152/jappl.1997.83.5.1461", "9375306"]}, {"Citation": "Davis J.M., Murphy E.A., McClellan J.L., Carmichael M.D., Gangemi J.D. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am. J. Physiol. Integr. Comp. Physiol. 2008;295:R505\u2013R509. doi: 10.1152/ajpregu.90319.2008.", "ArticleIdList": ["10.1152/ajpregu.90319.2008", "18579649"]}, {"Citation": "Fan D., Zhou X., Zhao C., Chen H., Zhao Y., Gong X. Anti-inflammatory, antiviral and quantitative study of quercetin-3-O-\u03b2-D-glucuronide in Polygonum perfoliatum L. Fitoterapia. 2011;82:805\u2013810. doi: 10.1016/j.fitote.2011.04.007.", "ArticleIdList": ["10.1016/j.fitote.2011.04.007", "21570451"]}, {"Citation": "Choi H.-J., Song J.H., Kwon D.-H. Quercetin 3-rhamnoside Exerts Antiinfluenza A Virus Activity in Mice. Phytother. Res. 2011;26:462\u2013464. doi: 10.1002/ptr.3529.", "ArticleIdList": ["10.1002/ptr.3529", "21728202"]}, {"Citation": "Smith M., Smith J.C. Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface. ChemRxiv. 2020 doi: 10.26434/chemrxiv.11871402.v3.", "ArticleIdList": ["10.26434/chemrxiv.11871402.v3"]}, {"Citation": "Omar S. In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and angiotensin converting enzyme 2 (ACE2) from natural products: Quercetin, hispidulin, and cirsimaritin exhibited better potential inhibition than hydroxy-chloroquine against COVID-19 main protease active site and ACE2. ChemRxiv. 2020 doi: 10.26434/chemrxiv.12181404.", "ArticleIdList": ["10.26434/chemrxiv.12181404"]}, {"Citation": "Adem S., Eyupoglu V., Sarfraz I., Rasul A., Ali M. Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against Corona. Preprints. 2020 doi: 10.20944/preprints202003.0333.v1.", "ArticleIdList": ["10.20944/preprints202003.0333.v1", "PMC8957318", "35364308"]}, {"Citation": "Das S., Sarmah S., Lyndem S., Roy A.S. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J. Biomol. Struct. Dyn. 2020 doi: 10.1080/07391102.2020.1763201.", "ArticleIdList": ["10.1080/07391102.2020.1763201", "PMC7232884", "32362245"]}, {"Citation": "Mullen W., Boitier A., Stewart A.J., Crozier A. Flavonoid metabolites in human plasma and urine after the consumption of red onions: Analysis by liquid chromatography with photodiode array and full scan tandem mass spectrometric detection. J. Chromatogr. A. 2004;1058:163\u2013168. doi: 10.1016/S0021-9673(04)01476-1.", "ArticleIdList": ["10.1016/S0021-9673(04)01476-1", "15595664"]}, {"Citation": "Zhao J., Yang J., Xie Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. Int. J. Pharm. 2019;570:118642. doi: 10.1016/j.ijpharm.2019.118642.", "ArticleIdList": ["10.1016/j.ijpharm.2019.118642", "31446024"]}, {"Citation": "Williamson G., Kerimi A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem. Pharmacol. 2020;178:114123. doi: 10.1016/j.bcp.2020.114123.", "ArticleIdList": ["10.1016/j.bcp.2020.114123", "PMC7316054", "32593613"]}]}], "History": [{"Year": "2020", "Month": "11", "Day": "6"}, {"Year": "2020", "Month": "12", "Day": "16"}, {"Year": "2020", "Month": "12", "Day": "21"}, {"Year": "2020", "Month": "12", "Day": "30", "Hour": "1", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["33374214", "PMC7824064", "10.3390/biom11010010", "biom11010010"]}}]}